Jack Green Joins Verastem, Inc. as Chief Financial Officer

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the appointment of John “Jack” Green as Chief Financial Officer. Mr. Green was the former Chief Financial Officer of GTC Biotherapeutics and has held multiple senior finance roles in public and private biotechnology companies over the course of his career.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC